Welcome to LookChem.com Sign In|Join Free

CAS

  • or

23528-54-3

Post Buying Request

23528-54-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

23528-54-3 Usage

Description

C-[1-(4-METHOXY-PHENYL)-CYCLOPENTYL]-METHYLAMINE is a chemical compound characterized by a cyclopentyl group connected to a methylamine group, featuring a 4-methoxyphenyl substituent at the 1-position of the cyclopentyl ring. Its unique structure suggests potential interactions with biological targets in the central nervous system, indicating possible applications in various fields. Further research is essential to explore its properties and potential uses comprehensively.

Uses

Used in Pharmaceutical Industry:
C-[1-(4-METHOXY-PHENYL)-CYCLOPENTYL]-METHYLAMINE is used as a potential therapeutic agent for targeting the central nervous system due to its chemical structure that may allow it to interact with specific biological targets, potentially leading to the development of new treatments for neurological disorders.
Used in Research and Development:
In the field of scientific research, C-[1-(4-METHOXY-PHENYL)-CYCLOPENTYL]-METHYLAMINE serves as a valuable compound for studying its biological and pharmacological activities. It can be utilized in experiments to understand its interactions with various biological systems, contributing to the advancement of knowledge in chemistry and medicine.
Used in Drug Discovery:
C-[1-(4-METHOXY-PHENYL)-CYCLOPENTYL]-METHYLAMINE is employed as a lead compound in drug discovery processes. Its unique structure may offer insights into the design of new drugs with improved efficacy and selectivity, particularly for conditions related to the central nervous system.
Used in Chemical Synthesis:
In the chemical synthesis industry, C-[1-(4-METHOXY-PHENYL)-CYCLOPENTYL]-METHYLAMINE can be used as an intermediate or building block for the synthesis of more complex molecules with potential applications in various fields, including pharmaceuticals, materials science, and agrochemicals.

Check Digit Verification of cas no

The CAS Registry Mumber 23528-54-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,5,2 and 8 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 23528-54:
(7*2)+(6*3)+(5*5)+(4*2)+(3*8)+(2*5)+(1*4)=103
103 % 10 = 3
So 23528-54-3 is a valid CAS Registry Number.
InChI:InChI=1/C13H19NO/c1-15-12-6-4-11(5-7-12)13(10-14)8-2-3-9-13/h4-7H,2-3,8-10,14H2,1H3

23528-54-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name [1-(4-methoxyphenyl)cyclopentyl]methanamine

1.2 Other means of identification

Product number -
Other names (1-(4-methoxyphenyl)cyclopentyl)methanamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:23528-54-3 SDS

23528-54-3Relevant articles and documents

N2-(2-METHOXYPHENYL)PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR CANCER PREVENTION OR TREATMENT CONTAINING SAME AS ACTIVE INGREDIENT

-

Paragraph 0205; 0208; 0209, (2018/05/03)

The present invention relates to a N2-(2-methoxyphenyl)pyrimidine derivative, a preparation method thereof, and a pharmaceutical composition for the prevention or treatment of cancer comprising the same as an active ingredient. The N2-(2-methoxyphenyl)pyrimidine derivative, the optical isomer thereof, or the pharmaceutically acceptable salt thereof of the present invention is very effective in suppressing anaplastic lymphoma kinase (ALK) activity and as a result it can improve the effectiveness of treatment on cancer cells having anaplastic lymphoma kinase (ALK) fusion proteins such as EML4-ALK and NPM-ALK, so that it can be effectively used as a pharmaceutical composition for preventing or treating cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 23528-54-3